Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ryu Okada
Observed name:
Okada, Ryu
Institutions:
Research Institute for Clinical Oncology, Saitama Cancer Center,
Saitama University
Observed institutions:
Saitama Cancer Center,
Research Institute for Clinical Oncology, Saitama Cancer Center,
Saitama University
ORCID:
0000-0002-5610-8577
Observed ORCID:
0000-0002-5610-8577
OpenAlex ID:
A5010569178
ATM depletion induces proteasomal degradation of FANCD2 and sensitizes neuroblastoma cells to PARP inhibitors
2023
·
Sultana Parvin
, Jesmin Akter
, et al.
·
BMC Cancer
·
15
PDF
Polycomb EZH1 regulates cell cycle/5‐fluorouracil sensitivity of neuroblastoma cells in concert with MYCN
2022
·
Yoshitaka Shinno
, Hisanori Takenobu
, et al.
·
Cancer Science
·
10
Polycomb group protein BMI1 protects neuroblastoma cells against DNA damage-induced apoptotic cell death
2022
·
Nobuhiro Akita
, Ryu Okada
, et al.
·
Experimental Cell Research
·
8
PDF
L3MBTL2 maintains MYCN ‐amplified neuroblastoma cell proliferation through silencing NRIP3 and BRME1 genes
2024
·
Ryu Okada
, Hisanori Takenobu
, et al.
·
Genes to Cells
·
4
PDF
Synthetic lethality of EZH2 and DNMT Inhibition suppresses neuroblastoma proliferation via MYCN destabilization
2025
·
Yuki Endo
, Ryuichi P. Sugino
, et al.
·
BMC Cancer
·
3
PDF
Noncanonical PRC1.1 targets BTG2 to retain cyclin gene expression and cell growth in neuroblastoma
2025
·
Shunpei Satoh
, Mariko Hasegawa
, et al.
·
Oncogenesis
·
3
PDF
Show more works
View as search
Works count:
8
Citation count:
43
H-index:
4
I10-index:
2
Year
Topic
Type